A new study shows a product based on activated charcoal protects the gut microbiome in patients taking antibiotics. The Phase I clinical trial showed promising results. The study reported in the Journal of Infectious Diseases compared DAV132, with a placebo. “DAV132 was highly effective to protect the gut microbiome of moxafloxacin-treated healthy volunteers and may
